These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36894982)

  • 1. Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment.
    Maniga JN; Samuel M; John O; Rael M; Muchiri JN; Bwogo P; Martin O; Sankarapandian V; Wilberforce M; Albert O; Onkoba SK; Adebayo IA; Adeyemo RO; Akinola SA
    Malar J; 2023 Mar; 22(1):87. PubMed ID: 36894982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited Polymorphism in
    Maniga JN; Akinola SA; Odoki M; Odda J; Adebayo IA
    Infect Drug Resist; 2021; 14():5153-5163. PubMed ID: 34908849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda.
    Ocan M; Bwanga F; Okeng A; Katabazi F; Kigozi E; Kyobe S; Ogwal-Okeng J; Obua C
    BMC Infect Dis; 2016 Aug; 16(1):428. PubMed ID: 27543172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia.
    Jeang B; Zhong D; Lee MC; Atieli H; Yewhalaw D; Yan G
    Malar J; 2024 Jan; 23(1):36. PubMed ID: 38287365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda.
    Ocan M; Ashaba FK; Mwesigwa S; Edgar K; Kamya MR; Nsobya SL
    PLoS One; 2022; 17(5):e0268095. PubMed ID: 35511795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.
    Bakari C; Mandara CI; Madebe RA; Seth MD; Ngasala B; Kamugisha E; Ahmed M; Francis F; Bushukatale S; Chiduo M; Makene T; Kabanywanyi AM; Mahende MK; Kavishe RA; Muro F; Mkude S; Mandike R; Molteni F; Chacky F; Bishanga DR; Njau RJA; Warsame M; Kabula B; Nyinondi SS; Lucchi NW; Talundzic E; Venkatesan M; Moriarty LF; Serbantez N; Kitojo C; Reaves EJ; Halsey ES; Mohamed A; Udhayakumar V; Ishengoma DS
    Malar J; 2024 Mar; 23(1):71. PubMed ID: 38461239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda.
    Angwe MK; Mwebaza N; Nsobya SL; Vudriko P; Dralabu S; Omali D; Tumwebaze MA; Ocan M
    PLoS One; 2024; 19(6):e0305064. PubMed ID: 38837973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
    Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
    Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular surveillance of drug resistance: Plasmodium falciparum artemisinin resistance single nucleotide polymorphisms in Kelch protein propeller (K13) domain from Southern Pakistan.
    Ghanchi NK; Qurashi B; Raees H; Beg MA
    Malar J; 2021 Apr; 20(1):176. PubMed ID: 33827592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo.
    Mayengue PI; Niama RF; Kouhounina Batsimba D; Malonga-Massanga A; Louzolo I; Loukabou Bongolo NC; Macosso L; Ibara Ottia R; Kimbassa Ngoma G; Dossou-Yovo LR; Pembet Singana B; Ahombo G; Sekangue Obili G; Kobawila SC; Parra HJ
    BMC Infect Dis; 2018 Oct; 18(1):538. PubMed ID: 30373565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya.
    Musyoka KB; Kiiru JN; Aluvaala E; Omondi P; Chege WK; Judah T; Kiboi D; Nganga JK; Kimani FT
    Infect Genet Evol; 2020 Mar; 78():104121. PubMed ID: 31756512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
    Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
    Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
    Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
    Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine.
    Straimer J; Gandhi P; Renner KC; Schmitt EK
    J Infect Dis; 2022 Apr; 225(8):1411-1414. PubMed ID: 34216470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study.
    Uwimana A; Umulisa N; Venkatesan M; Svigel SS; Zhou Z; Munyaneza T; Habimana RM; Rucogoza A; Moriarty LF; Sandford R; Piercefield E; Goldman I; Ezema B; Talundzic E; Pacheco MA; Escalante AA; Ngamije D; Mangala JN; Kabera M; Munguti K; Murindahabi M; Brieger W; Musanabaganwa C; Mutesa L; Udhayakumar V; Mbituyumuremyi A; Halsey ES; Lucchi NW
    Lancet Infect Dis; 2021 Aug; 21(8):1120-1128. PubMed ID: 33864801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K13-propeller gene polymorphisms of Plasmodium falciparum and the therapeutic effect of artesunate among migrant workers returning to Guangxi, China (2014-2017).
    Li J; Shi Y; Zhang W; Yan H; Lin K; Wei S; Wei H; Yang Y; Huang S; Lu Y; Ma A; Qin J
    Malar J; 2019 Oct; 18(1):349. PubMed ID: 31619243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy.
    Ogouyèmi-Hounto A; Damien G; Deme AB; Ndam NT; Assohou C; Tchonlin D; Mama A; Hounkpe VO; Moutouama JD; Remoué F; Ndiaye D; Gazard DK
    Parasite; 2016; 23():28. PubMed ID: 27443837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
    Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B
    Malar J; 2014 Dec; 13():472. PubMed ID: 25471113
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Montenegro M; Neal AT; Posada M; De Las Salas B; Lopera-Mesa TM; Fairhurst RM; Tobon-Castaño A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.